Co-Diagnostics (CODX) Reports In-Line Q3 EPS

Co-Diagnostics (NASDAQ: CODX) reported Q3 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $100 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• MicroVision enters agreement to sell up to $42 million in common stock